The Rifampicin Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2022-2028). Rifampicin is an antibiotic used to treat several types of mycobacterial infections, including Mycobacterium avium complex, leprosy, and in combination with other antibacterial drugs to treat latent or active tuberculosis. Get Sample Copy of Rifampicin […]
